Skip to main content

Table 2 Optic toxicity after 3D RT for sinonasal malignancies

From: Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation

Ref.

#

Median follow up (mo)

Stage

RT

Presciption dose

Local control

Dose to the optic pathway

Vision impairment

Blindness

Homma [10]§

47

55.2

T4: 85.1%

3D

65 Gy/26 frx or 70 Gy/35 frx

83.0%

n/a

42.1% grade 3 or 4 optic toxicity at 2 years (CTCAE v.3); severe optic toxicity is 56% in patients with orbital invasion

None reported

Gabriele [11]§

31

42

T4: 38.7%

3D

60-68 Gy/30–34 frx

61.3%

ON:

None

2 due to disease progression, 1 due to cataract

5 yr LC:

-Ipsilateral: 5.7-46.1 Gy

-Postoperative: 74%

-Contralateral: 3.8-25.6 Gy

-Definitive: 20%

OC: 11.3-36.2 Gy

Pommier [12]§

40

19

T3-4: 55%

3D

Definitive: 63.5 Gy¶

80%

ON:

None

1 patient 3 years after RT due to vascular glaucoma

Postoperative: 61.8 - 63.1 Gy¶

-Ipsilateral 48.1 Gy¶

2 Gy/frx

-Contralateral 22.0 Gy¶

OC: 43.5 Gy¶

Roa [13]

39

54

IV: 53.8%

3D

Definitive: 68.4 Gyǂ;

56.4%

n/a

1 retinal artery occlusion and 1 optic neuropathy after 68.4 Gy delivered.

None

Postoperative: 55.8 -67.8 Gyǂ

     

1.8-2 Gy/frx

    
  1. # number of patients, n/a not available, frx fraction, †postoperative, *associated with vision impairment or blindness, ON optic nerve, OC optic chiasm, ǂ median dose, ¶ average dose, pt patient, chemotherapy in a portion of pts§.